Literature DB >> 24759030

[The evolution and curative effect of diffuse large B cell lymphoma treatment in China].

Wenqi Jiang1, Huiqiang Huang1.   

Abstract

Mesh：

Year:  2014        PMID： 24759030     DOI： 10.3760/cma.j.issn.0253-2727.2014.04.025

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  3 in total

1.  MicroRNA-383-5p predicts favorable prognosis and inhibits the progression of diffuse large B-cell lymphoma.

Authors:  Li-Yan Chen; Bi-Qing Han; Xiao-Min Zhang; Xing-Bao Yu; Dan-Dan Yao; Li-Qian Yu
Journal:  Oncol Lett       Date:  2021-05-06       Impact factor: 2.967

2.  Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195.

Authors:  Li-Yan Chen; Xiao-Min Zhang; Bi-Qing Han; Hai-Bin Dai
Journal:  Onco Targets Ther       Date:  2020-06-12       Impact factor: 4.147

3.  Low Expression of 14-3-3beta Is Associated With Adverse Survival of Diffuse Large B-Cell Lymphoma Patients.

Authors:  Chaoping Li; Zhaoming Li; Mingzhi Zhang
Journal:  Front Med (Lausanne)       Date:  2019-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.